Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ProShares Ultra QQQ ETF (QLD) vs UnitedHealth Group Inc (UNH) Price & Performance

ProShares Ultra QQQ ETFTrade
UnitedHealth Group IncTrade

Price performance (Past 24H)

Key statistics

ProShares Ultra QQQ ETF vs UnitedHealth Group Inc — how do they compare? ProShares Ultra QQQ ETF trades at $88.28, while UnitedHealth Group Inc trades at $431.76 (market cap $396.27B). The key difference: UnitedHealth Group Inc pays a 2.13% dividend while ProShares Ultra QQQ ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, ProShares Ultra QQQ ETF nearer its low. Which is the better fit depends on your goals.

QLDUNH
Sector
Leveraged / InverseHealth
52-Week High
$100.53$436.35
52-Week Low
$57.16$237.77
Market Cap
$396.27B
Enterprise Value
$442.96B
Dividend Yield
2.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ProShares Ultra QQQ ETF

QLD, the ProShares Ultra QQQ ETF, trades at $86.06, up 0.17% on the day, with a bearish technical signal driven by moving averages. The ETF, which provides 2x daily leveraged exposure to the Nasdaq-100 index, has delivered over 10,000% total return since inception, demonstrating powerful long-term compounding. Recent news highlights its role in tech-focused strategies amid a Nasdaq comeback, though leveraged structure amplifies volatility.

Outlook is mixed: technicals suggest near-term caution, but long-term growth potential remains tied to tech sector performance. Key risks include daily rebalancing effects in volatile markets and significant drawdowns, as seen historically. Investors should weigh leveraged benefits against inherent volatility and holding period considerations.

UnitedHealth Group Inc

UnitedHealth Group (UNH) trades at $421.55, down 1.07% on the day, with a bullish technical outlook supported by moving averages and ADX signals. The company reported strong Q2 2026 EPS of $6.38, beating estimates, and maintains robust cash flow generation. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns through dividends and buybacks.

UNH presents a favorable investment case with 82.7% analyst buy ratings and a $476.50 consensus price target, implying 13% upside. Risks include regulatory scrutiny from lawsuits and Medicaid fraud allegations, while demographic trends and operational efficiency support long-term growth. The stock's valuation at a P/E of 31.74 reflects premium pricing relative to historical margins.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ProShares Ultra QQQ ETF

QLD is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the NASDAQ-100 Index. It achieves 2x leverage by investing in financial instruments such as swaps and is designed as a tactical trading tool for investors with a bullish (long) view on the NASDAQ-100. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.

Read more on QLD

About UnitedHealth Group Inc

UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.

Read more on UNH